Regulatory & Legal

With its lead autoimmune drug nearing FDA review and a new $250M in funding, Zenas BioPharma prepares for a major leap from R&D to market.

Inc. names Tiffany Whitlow to its Female Founders 500, validating Acclinate's model of making inclusive clinical research a profitable, high-growth venture.

The junior miner's inclusion in the GDXJ and strategic move to Miami aim to boost investor visibility and streamline access to its Colombian gold projects.

Historic auction house Bonhams partners with analytics firm ARTDAI, betting on AI and big data to gain a competitive edge in the evolving art world.

After a protracted legal battle in the Marshall Islands, George Economou's Sphinx Investment Corp. has terminated its takeover offer for Performance Shipping.

The body contouring firm faces investor unease over a delayed annual report, even as it points to a sales rebound from a new marketing push.

Fintech giant Ant International partners with World Cup champions Argentina, leveraging football fever to conquer Asia's booming digital payments market.

A landmark deal between Cielo Waste Solutions and the Lheidli T’enneh Nation aims to build a green fuel facility, charting a new course for Indigenous-led energy.

As maternity care deserts expand, one rural hospital is using wearable tech to bring vital prenatal monitoring to high-risk mothers right in their homes.

A new survey reveals a grim reality: 55% of Americans now use credit cards for necessities, creating a 'survival gap' fueled by high APRs and inflation.

A landmark partnership provides over $700k to launch Singapore's first law centre dedicated to individuals with non-visible conditions like autism and ADHD.

Two shipping giants unite to dominate the LNG bunkering market, accelerating the maritime industry's transition to cleaner fuels amid surging demand.

With a 450-year heritage, Queen Elizabeth's School opens in Gurugram, intensifying the battle for supremacy in India's booming international school sector.

Swiss lab-tech firm Tecan posts a major loss after strategic write-downs but launches an ambitious 'Rewired' plan to chase a CHF 1B sales target.

After a failed reverse stock split, shipping firm OceanPal faces delisting. Can its ambitious AI subsidiary, SovereignAI, save it from the exchange?

A battle for Carver Bancorp's future erupts as its board rejects a turnaround expert, sparking a fierce fight with its largest shareholder.

A new analysis of the PREVENT equations clarifies how diabetes and kidney health impact heart risk, enabling earlier, more tailored patient care.

Amid crippling labour shortages, the federal government offers a temporary reprieve to rural employers, but critics warn of the long-term costs.

OTC-listed ProText Mobility unveils an audacious plan to tokenize biotech assets, partner with major banks, and uplist to a major exchange. Can it deliver?

A new report projects massive growth in cardiovascular devices, driven by AI and minimally invasive tech. But can the healthcare system afford this progress?